Complex DNA, Delivered Fast – Fuel Your Advanced Therapy Pipeline

Section 1: The Challenge
Designing vectors for biologics, viral vectors, and RNA therapeutics often requires DNA sequences that are long, GC-rich, or contain repeats. Traditional suppliers can be slow, low-yield, or unable to synthesize certain fragments at all.

Section 2: The Solution
ENFINIA™ DNA empowers teams like Asimov’s to:

Receive high-complexity fragments up to >5 kb
Access sequences previously considered unmakeable
Cut cloning timelines from weeks to days

Section 3: Real Results

Nearly 40% of sequences delivered were unmakeable elsewhere
6–8 business day turnaround with NGS-verified accuracy

Job Title

Name Country your

Company Name

Phone Number

First Name

Last Name

Country

What is your Primary Research Area?

“This content is brought to you by Elegen, a global leader in DNA synthesis solutions. Insights are based on real-world use cases to help organizations accelerate advanced therapy development, streamline cloning workflows, and deliver reliable, high-complexity DNA for cutting-edge therapeutics.”

Elegen Managed Detection will use the data provided hereunder in accordance with the Privacy Statement.